Meta AnalysisID 2827

布洛芬、对乙酰氨基酚或吲哚美辛治疗动脉导管未闭的Meta分析的系统文献综述

CRD42020165457

This study is a systematic review of meta-analyses and network meta-analyses of the safety and efficacy of ibuprofen, paracetamol/acetaminophen, or indomethacin for the treatment of PDA in preterm and low birth weight in

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
2827
Evidence Id
11385
Core Evidence Id
11385
Source Meta Analysis Id
2770
Herb2 Meta Analysis Id
HBMA002770
Crd Id
CRD42020165457
Title
A systematic literature review of meta-analyses for the treatment of patent ductus arteriosus (PDA) with ibuprofen, paracetamol/acetaminophen, or indomethacin
Review Question
This study is a systematic review of meta-analyses and network meta-analyses of the safety and efficacy of ibuprofen, paracetamol/acetaminophen, or indomethacin for the treatment of PDA in preterm and low birth weight infants
Study Type Included
Meta-analyses and network meta-analyses of PDA treatment in randomzied controlled trials and observational studies.
Condition Being Studied
Patency of ductus arteriosus is essential during pregnancy for fetal survival. In relation to newborns, the ductus closes after delivery within the first three days of life. While with preterm infants, the closure may delay, resulting in several complications such as hemodynamically significant left to right shunt, prolongation of ventilatory support need, increased risk of congestive cardiac failure, intraventricular hemorrhage (IVH), pulmonary edema, bronchopulmonary dysplasia, renal failure, necrotizing enterocolitis (NEC), feeding intolerance, and reduced overall survival rate. PDA is defined as failure of ductus arteriosus to close within 72 hours of life. PDA is one of the most common cardiac disorders among premature infants, especially those under 28 weeks old of gestational age (GA)
Participant
any neonates diagnosed with PDA treated with ibuprofen, paracetamol/acetaminophen, or indomethacin
Animal
Human Disease Modelled
Intervention
ibuprofen, paracetamol/acetaminophen, or indomethacin
Comparator Control
ibuprofen, paracetamol/acetaminophen, indomethacin, placebo, control, no treatment
Main Outcome
Primary: if there are evidence that Ibuprofen, indomethacin and paracetamol/acetaminophen are more effective than placebo/no treatment for closure of PDA in terms of PDA closure Secondary: if there are evidence that Ibuprofen, indomethacin and paracetamol/acetaminophen are more effective than placebo/no treatment for closure of PDA in terms of risk of neonatal mortality, oliguria, intestinal perforation, bronchopulmonary dysplasia, intraventricular haemorrhage, necrotizing enterocolitis, gastrointestinal bleeding or stools positive for occult blood, duration of ventilator support (days), serum/plasma levels of creatinine after treatment (µmol/L), and neurodevelopmental impairment Measures of effect none.
Outcome Measure
Additional Outcome
none Measures of effect none.
Study Method
Systematic review
Keyword
Humans
Contact
Daoud Al-Badriyeh [email protected]
Organisational Affiliation
Qatar University http://www.qu.edu.qa/
Funding Source
This research will not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Qatar
Review Stage
Review Ongoing
First Submission Date
2020-01-14
Registration Date
2020-04-28
Anticipated Start Date
2020-02-01
Anticipated Completion Date
2021-02-28
Title Cn
布洛芬、对乙酰氨基酚或吲哚美辛治疗动脉导管未闭的Meta分析的系统文献综述
Title En
A systematic literature review of meta-analyses for the treatment of patent ductus arteriosus (PDA) with ibuprofen, paracetamol/acetaminophen, or indomethacin
Bilingual Status
complete